ClearPath Development Company Launches Third Collaboration Under Strategic Partnership With Astellas Pharma To Develop Staphylococcus Aureus Vaccine With Boston Children’s Hospital

December 19, 2017

Responsive image

ROCKVILLE, Md. and BOSTON, Dec. 19, 2017 /PRNewswire-USNewswire/ — ClearPath Development Company (ClearPath) announced today it has initiated a third research collaboration with Astellas Pharma Inc. to combat infections. The new collaboration, executed by a ClearPath subsidiary,…

Category: Precious Metals